26 studies found for:    "Carcinoma, Pancreatic Ductal"
Show Display Options
Rank Status Study
1 Unknown  Efficacy Study of Gemcitabine, Paclitaxel, and Irradiation in the Treatment of Pancreatic Cancer
Condition: Carcinoma, Pancreatic Ductal
Interventions: Drug: Paclitaxel and gemcitabine;   Procedure: Hyperfractionated external beam irradiation
2 Not yet recruiting Correlation of Serum CA19-9 Levels With Levels in Saliva and Urine of Patients With Ductal Adenocarcinoma of the Pancreas
Condition: Carcinoma, Pancreatic Ductal
Intervention: Other: samples of blood, saliva and urine
3 Recruiting Study of Changes and Characteristics of Genes in Patients With Pancreatic Cancer for Better Treatment Selection
Condition: Carcinoma, Pancreatic Ductal
Intervention: Genetic: Molecular Profiling
4 Recruiting Parvovirus H-1 (ParvOryx) in Patients With Metastatic Inoperable Pancreatic Cancer
Condition: Carcinoma, Pancreatic Ductal
Intervention: Drug: Parvovirus H-1 (H-1PV)
5 Recruiting Safety and Efficacy Evaluation of iAPA-DC/CTL Combined Gemcitabine Therapy on Advanced Pancreatic Cancer
Condition: Carcinoma, Pancreatic Ductal
Interventions: Other: iAPA-DC/CTL adoptive cellular immunotherapy;   Drug: Gemcitabine
6 Recruiting Pancreatic Cancer Can be Detected by Adrenomedullin in New Onset Diabetes Patients
Conditions: Diabetes Mellitus, Adult-Onset;   Diabetes Complications;   Carcinoma, Pancreatic Ductal;   Pancreatic Neoplasm
Intervention:
7 Recruiting According CTC to Compare the Influences of Different Methods to Remove the PDAC
Conditions: Carcinoma, Pancreatic Ductal;   Circulating Tumor Cells
Interventions: Procedure: routine surgery;   Procedure: no-touch surgery;   Procedure: laparoscopic surgery
8 Recruiting An Evaluation of the Utility of the ExSpiron Respiratory Variation Monitor During Upper GI Endoscopy
Conditions: Biliary Tract Diseases;   Stomach Neoplasms;   Carcinoma, Pancreatic Ductal;   Barrett Esophagus
Intervention: Device: ExSpiron Respiratory Variation Monitor
9 Completed Circulating Tumor Cells in Operative Blood
Condition: Carcinoma, Pancreatic Ductal
Interventions: Procedure: Peripheral/Central Venous Blood Draw;   Procedure: Peritoneal Wash
10 Completed Atu027 Plus Gemcitabine in Advanced or Metastatic Pancreatic Cancer (Atu027-I-02)
Condition: Carcinoma, Pancreatic Ductal
Interventions: Drug: Atu027 & gemcitabine in lead in safety period;   Drug: Atu027 & gemcitabine in treatment arm 1;   Drug: Atu027 & gemcitabine in treatment arm 2
11 Completed A Study of AGS-1C4D4 in Pancreatic Cancer Subjects Previously Treated in Protocol 2008002
Conditions: Carcinoma, Pancreatic Ductal;   Pancreatic Cancer;   Pancreatic Disease
Interventions: Biological: AGS-1C4D4;   Biological: gemcitabine
12 Completed A Phase 1 Study of CC-486 as a Single Agent and in Combination With Carboplatin or ABI-007 in Subjects With Relapsed or Refractory Solid Tumors
Conditions: Urinary Bladder Neoplasms;   Carcinoma, Transitional Cell;   Ovarian Neoplasms;   Fallopian Tube Neoplasms;   Peritoneal Neoplasms;   Carcinoma, Non-Small-Cell Lung;   Carcinoma, Pancreatic Ductal;   Tumor Virus Infections
Interventions: Drug: CC-486;   Drug: Carboplatin;   Drug: ABI-007
13 Terminated Amatuximab for High Mesothelin Cancers
Conditions: Carcinoma, Pancreatic Ductal;   Mesothelioma;   Ovarian Neoplasms;   Carcinoma, Non-Small-Cell Lung
Intervention: Drug: Amatuximab (MORab-009)
14 Unknown  Chemotherapy Selection Based on Therapeutic Targets for Advanced Pancreatic Cancer
Condition: Carcinoma, Pancreatic Ductal
Interventions: Drug: Targeted Therapy Tailored Treatment;   Drug: Standard Chemotherapy
15 Completed A Study of AGS-1C4D4 Given in Combination With Gemcitabine in Subjects With Metastatic Pancreatic Cancer
Conditions: Carcinoma, Pancreatic Ductal;   Pancreatic Cancer;   Pancreatic Disease
Interventions: Biological: AGS-1C4D4;   Biological: Gemcitabine
16 Completed
Has Results
Study Of Gemcitabine Plus AG-013736 Versus Gemcitabine For Advanced Pancreatic Cancer.
Condition: Carcinoma, Pancreatic Ductal
Interventions: Drug: AG-013736;   Drug: Gemcitabine;   Drug: placebo
17 Recruiting Phase II Study of Preoperative FOLFIRINOX Versus Gemcitabine/Nab-Paclitaxel in Patients With Resectable Pancreatic Cancer
Conditions: Resectable Pancreatic Cancer;   Pancreatic Ductal Carcinoma
Interventions: Drug: FOLFIRINOX;   Drug: Gemcitabine/nab-Paclitaxel;   Radiation: Radiation therapy;   Drug: Capecitabine
18 Recruiting Phase Ib/II Study of MEDI4736 Evaluated in Different Combinations in Metastatic Pancreatic Ductal Carcinoma
Condition: Metastatic Pancreatic Ductal Adenocarcinoma
Interventions: Drug: MEDI4736 in combination with nab-paclitaxel and gemcitabine;   Drug: MEDI4736 in combination with AZD5069
19 Recruiting Phase II Study of MEDI4736 Monotherapy or in Combinations With Tremelimumab in Metastatic Pancreatic Ductal Carcinoma
Condition: Metastatic Pancreatic Ductal Adenocarcinoma
Interventions: Drug: MEDI4736 monotherapy;   Drug: tremelimumab+MEDI4736
20 Completed Pilot Phase 2 Study to Investigate the Preliminary Efficacy and Safety of INNO-206 in Advanced Pancreatic Cancer
Condition: Pancreatic Ductal Adenocarcinoma
Intervention: Drug: INNO-206

   Previous Page Studies Shown (1-20) Next Page (21-26) Show next page of results    Last Page
Indicates status has not been verified in more than two years